Strive Asset Management has raised $750 million to pursue the strategy while Ramaswamy runs to be Ohio’s governor.

Biotech companies offer huge growth opportunities, and you can often get in early at a reasonable price. It’s important to look for a company with a strong pipeline and a focus on a high-growth ...

The companies Pathos AI, Taysha Gene Therapies, and Abeona Therapeutics bagged the biggest biotech funding rounds overall in ...

In this era of escalating trade tensions and geopolitical uncertainty, the U.S. cannot afford to cede another critical ...

They note that the explosion in small cap biotech companies has meaningfully driven ... reaching around negative 100% in 2023. For the Nasdaq Biotech Index (NBI), margins have been more stable ...

Drug developers aren’t expected to come back to the US equity markets in full force until next year — lagging other ...

For all the attention on U.S.-China AI competition, new studies point to China’s rapid rise in biotechnology, especially for ...

The 10 most innovative biotech companies of 2025 are leveraging AI ... Trial results published in 2024 showed 100% accuracy of the DarwinOncoTarget tool at predicting response to drugs called ...

(Reuters) -Merck has held talks to buy Swiss biotech MoonLake Immunotherapeutics for more than $3 billion, the Financial ...

Investing in biotech stocks is a fantastic way to grow your money over time. This is because in the early days of these companies' growth stories, their stock prices often remain accessible -- and ...